Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Osamu Takeuchi

Showing results (81-90 of 305) with videos related to

Pageof 31
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2002
Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signalingMasahiro Yamamoto, Shintaro Sato, Kiyotoshi Mori, et al.
Clinical & Experimental Metastasis|November 1, 2012
Combined effect of dehydroxymethylepoxyquinomicin and gemcitabine in a mouse model of liver metastasis of pancreatic cancerKeiichi Suzuki, Koichi Aiura, Sachiko Matsuda, et al.
Cancer Science|September 28, 2020
Glycogen synthase kinase-3β participates in acquired resistance to gemcitabine in pancreatic cancerMasahiro Uehara, Takahiro Domoto, Satoshi Takenaka, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2005
Essential role of BAX,BAK in B cell homeostasis and prevention of autoimmune diseaseOsamu Takeuchi, Jill Fisher, Heikyung Suh, et al.
Nature Immunology|August 12, 2009
TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritisTatsukata Kawagoe, Osamu Takeuchi, Yoshitsugu Takabatake, et al.
Frontiers in Immunology|January 21, 2026
Regnase-1 in cDC1 controls T cell priming and shapes the dynamics of experimental autoimmune encephalomyelitisXingyu Rong, Hai Wang, Shintaro Muraoka, et al.
Nature Communications|July 9, 2024
UPF1 plays critical roles in early B cell developmentNoriki Iwai, Kotaro Akaki, Fabian Hia, et al.
Cancer Drug Resistance (Alhambra, Calif.)|February 6, 2024
Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancerMasahiro Uehara, Takahiro Domoto, Satoshi Takenaka, et al.
Immunity|March 26, 2011
Antiviral protein Viperin promotes Toll-like receptor 7- and Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cellsTatsuya Saitoh, Takashi Satoh, Naoki Yamamoto, et al.
Molecular and Cellular Biochemistry|June 23, 2020
Bcl-2/Bcl-xL inhibitor navitoclax increases the antitumor effect of Chk1 inhibitor prexasertib by inducing apoptosis in pancreatic cancer cells via inhibition of Bcl-xL but not Bcl-2Yoshihito Morimoto, Kimihiko Takada, Osamu Takeuchi, et al.
Pageof 31

Showing results (81-90 of 305) with videos related to

Sort By:
Pageof 31
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2002
Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signalingMasahiro Yamamoto, Shintaro Sato, Kiyotoshi Mori, et al.
Clinical & Experimental Metastasis|November 1, 2012
Combined effect of dehydroxymethylepoxyquinomicin and gemcitabine in a mouse model of liver metastasis of pancreatic cancerKeiichi Suzuki, Koichi Aiura, Sachiko Matsuda, et al.
Cancer Science|September 28, 2020
Glycogen synthase kinase-3β participates in acquired resistance to gemcitabine in pancreatic cancerMasahiro Uehara, Takahiro Domoto, Satoshi Takenaka, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2005
Essential role of BAX,BAK in B cell homeostasis and prevention of autoimmune diseaseOsamu Takeuchi, Jill Fisher, Heikyung Suh, et al.
Nature Immunology|August 12, 2009
TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritisTatsukata Kawagoe, Osamu Takeuchi, Yoshitsugu Takabatake, et al.
Frontiers in Immunology|January 21, 2026
Regnase-1 in cDC1 controls T cell priming and shapes the dynamics of experimental autoimmune encephalomyelitisXingyu Rong, Hai Wang, Shintaro Muraoka, et al.
Nature Communications|July 9, 2024
UPF1 plays critical roles in early B cell developmentNoriki Iwai, Kotaro Akaki, Fabian Hia, et al.
Cancer Drug Resistance (Alhambra, Calif.)|February 6, 2024
Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancerMasahiro Uehara, Takahiro Domoto, Satoshi Takenaka, et al.
Immunity|March 26, 2011
Antiviral protein Viperin promotes Toll-like receptor 7- and Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cellsTatsuya Saitoh, Takashi Satoh, Naoki Yamamoto, et al.
Molecular and Cellular Biochemistry|June 23, 2020
Bcl-2/Bcl-xL inhibitor navitoclax increases the antitumor effect of Chk1 inhibitor prexasertib by inducing apoptosis in pancreatic cancer cells via inhibition of Bcl-xL but not Bcl-2Yoshihito Morimoto, Kimihiko Takada, Osamu Takeuchi, et al.
Pageof 31